Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Corticosteroid insensitivity is reversed by formoterol via phosphoinositide‐3‐kinase inhibition
Rossios, C, To, Y, Osoata, G, Ito, M, Barnes, PJ, Ito, K
Published in British journal of pharmacology (01.10.2012)
Published in British journal of pharmacology (01.10.2012)
Get full text
Journal Article
Correlation between Fatty Acid Transport Proteins and Phosphoinositide 3-Kinase Pathway in Breast Cancer
Acharya, Ranjitha, Nalilu, Suchetha Kumari, Shetty, Shilpa Sharathraj, Shetty, Abhijith Sudhakar, Monteiro, Flama, Ganeshkodi, Roopashree Padmanabha
Published in Biomedical and Biotechnology Research Journal (01.04.2024)
Published in Biomedical and Biotechnology Research Journal (01.04.2024)
Get full text
Journal Article
Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3‐kinase antagonist, in adult patients with advanced solid malignancies
De Buck, Stefan S., Jakab, Annamaria, Boehm, Markus, Bootle, Douglas, Juric, Dejan, Quadt, Cornelia, Goggin, Timothy K.
Published in British journal of clinical pharmacology (01.09.2014)
Published in British journal of clinical pharmacology (01.09.2014)
Get full text
Journal Article
Role of Class III phosphoinositide 3‐kinase in the brain development: possible involvement in specific learning disorders
Inaguma, Yutaka, Matsumoto, Ayumi, Noda, Mariko, Tabata, Hidenori, Maeda, Akihiko, Goto, Masahide, Usui, Daisuke, Jimbo, Eriko F., Kikkawa, Kiyoshi, Ohtsuki, Mamitaro, Momoi, Mariko Y., Osaka, Hitoshi, Yamagata, Takanori, Nagata, Koh‐ichi
Published in Journal of neurochemistry (01.10.2016)
Published in Journal of neurochemistry (01.10.2016)
Get full text
Journal Article
A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3‐kinase/v‐akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma
Korkolopoulou, Penelope, Levidou, Georgia, Trigka, Eleni‐Andriana, Prekete, Niki, Karlou, Maria, Thymara, Irene, Sakellariou, Stratigoula, Fragkou, Paraskevi, Isaiadis, Dimitrios, Pavlopoulos, Petros, Patsouris, Efstratios, Saetta, Angelica A.
Published in BJU international (01.12.2012)
Published in BJU international (01.12.2012)
Get full text
Journal Article
Characterizing the Sources of Pharmacokinetic Variability for TAK‐117 (Serabelisib), an Investigational Phosphoinositide 3‐Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy
Patel, Chirag G., Rangachari, Lakshmi, Patti, Mark, Griffin, Celina, Shou, Yaping, Venkatakrishnan, Karthik
Published in Clinical pharmacology in drug development (01.07.2019)
Published in Clinical pharmacology in drug development (01.07.2019)
Get full text
Journal Article
CYP3A but not P‐gp plays a relevant role in the in vivo intestinal and hepatic clearance of the delta‐specific phosphoinositide‐3 kinase inhibitor leniolisib
De Buck, Stefan, Kucher, Klaus, Hara, Hisanori, Gray, Cathy, Woessner, Ralph
Published in Biopharmaceutics & drug disposition (01.09.2018)
Published in Biopharmaceutics & drug disposition (01.09.2018)
Get full text
Journal Article
Profilin tyrosine phosphorylation in poly‐l‐proline‐binding regions inhibits binding to phosphoinositide 3‐kinase in Phaseolus vulgaris
Aparicio‐Fabre, Rosaura, Guillén, Gabriel, Estrada, Georgina, Olivares‐Grajales, Juan, Gurrola, Georgina, Sánchez, Federico
Published in The Plant journal : for cell and molecular biology (01.08.2006)
Published in The Plant journal : for cell and molecular biology (01.08.2006)
Get full text
Journal Article
Autophosphorylation of p110δ phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo
Vanhaesebroeck, Bart, Higashi, Kyochiro, Raven, Catherine, Welham, Melanie, Anderson, Simon, Brennan, Paul, Ward, Stephen G., Waterfield, Michael D.
Published in The EMBO journal (01.03.1999)
Published in The EMBO journal (01.03.1999)
Get full text
Journal Article
PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma
Bi, Jing, Min, Zhihui, Yuan, Honglei, Jiang, Zhilong, Mao, Ruolin, Zhu, Tao, Liu, Chunfang, Zeng, Yuzhen, Song, Juan, Du, Chunling, Chen, Zhihong
Published in Clinical and translational medicine (28.02.2020)
Published in Clinical and translational medicine (28.02.2020)
Get full text
Journal Article
The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma
Leaker, B. R., Barnes, P. J., O'Connor, B. J., Ali, F. Y., Tam, P., Neville, J., Mackenzie, L. F., MacRury, T.
Published in Clinical and experimental allergy (01.09.2014)
Published in Clinical and experimental allergy (01.09.2014)
Get full text
Journal Article
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects
Ino, Hiroko, Wilson, Robert, Terao, Takumi, Ogura, Hirofumi, Igarashi, Harue, Cahn, Anthony, Numachi, Yotaro
Published in Clinical pharmacology in drug development (01.01.2019)
Published in Clinical pharmacology in drug development (01.01.2019)
Get full text
Journal Article